Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse...
65 insider purchases on record · latest filing 2026-08-25.
Insiders have also filed 175 sale transactions at PGEN.